Filing Details
- Accession Number:
- 0001140361-16-046816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-06 10:24:40
- Reporting Period:
- 2016-01-04
- Filing Date:
- 2016-01-06
- Accepted Time:
- 2016-01-06 10:24:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403769 | Sue Bailey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-04 | 5,760 | $11.67 | 34,260 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-04 | 5,760 | $38.97 | 28,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-01-04 | 2,880 | $16.13 | 31,380 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-04 | 2,880 | $38.77 | 28,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-01-04 | 2,880 | $22.02 | 31,380 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-04 | 2,880 | $38.46 | 28,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2016-01-04 | 5,760 | $0.00 | 5,760 | $11.67 |
| Common Stock | Stock Option | Disposition | 2016-01-04 | 2,880 | $0.00 | 2,880 | $16.13 |
| Common Stock | Stock Option | Disposition | 2016-01-04 | 2,880 | $0.00 | 2,880 | $22.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,880 | 2019-05-20 | No | 4 | M | Direct | |
| 2,880 | 2020-05-19 | No | 4 | M | Direct | |
| 4,320 | 2021-05-18 | No | 4 | M | Direct |
Footnotes
- Consists of an option granted under the company's stock incentive plan on May 21, 2009.
- Consists of an option granted under the company's stock incentive plan on May 20, 2010.
- Consists of an option granted under the company's stock incentive plan on May 19, 2011.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.58 to $39.16, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.11, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.27 to $38.68, inclusive.
- The option vested in three equal installments in May 2010, 2011 and 2012.
- The option vested in three equal installments in May 2011, 2012 and 2013.
- The option vested in three equal installments in May 2012, 2013 and 2014.
Billionaire Hedge Funds
